World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
67
Citations
36544
World Ranking
2478
National Ranking
16

Batsheva Kerem publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Batsheva Kerem sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 155 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Batsheva Kerem D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Batsheva Kerem sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 67 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Batsheva Kerem is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily centers on medical sciences, with a specific focus on pulmonary and respiratory medicine, molecular biology, and genetics. The scientist has contributed extensively to the study of cystic fibrosis and related genetic disorders.

Their recent research publications include:

  • 3D genome organization contributes to genome instability at fragile sites, 2020, Nature Communications
  • New approaches to genetic therapies for cystic fibrosis, 2020, Journal of Cystic Fibrosis
  • Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation, 2023, Journal of Cystic Fibrosis
  • Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation, 2021, Journal of Cystic Fibrosis
  • Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation, 2021, Journal of Cystic Fibrosis

Batsheva Kerem frequently publishes in the following venues:

  • Journal of Cystic Fibrosis
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cell Reports
  • Nucleic Acid Therapeutics

Frequent coauthors collaborating with Batsheva Kerem include:

  • Yifat S. Oren
  • E. Ozeri-Galai
  • Eitan Kerem
  • Gili Hart
  • Michael Wilschanski

The main fields of study encompass:

  • Medicine

Within this broad field, subfields of focus include:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Genetics
  • Oncology
  • Electrical and Electronic Engineering

Their main topics of research cover:

  • Cystic Fibrosis Research Advances
  • Neonatal Respiratory Health Research
  • DNA Repair Mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Genetics and Neurodevelopmental Disorders
  • Tracheal and airway disorders
  • Energy Harvesting in Wireless Networks

Batsheva Kerem has been recognized as a member of the European Molecular Biology Organization (EMBO).

Best Publications

  • Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

    John R. Riordan;Johanna M. Rommens;Bat Sheva Kerem;N. O.A. Alon

  • Identification of the cystic fibrosis gene: genetic analysis.

    Bat Sheva Kerem;Johanna M. Rommens;Janet A. Buchanan;Danuta Markiewicz

  • Identification of the cystic fibrosis gene: Chromosome walking and jumping

    Johanna M. Rommens;Michael C. Iannuzzi;Bat Sheva Kerem;Mitchell L. Drumm

  • The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

    Eitan Kerem;Mary Corey;Bat-sheva Kerem;Johanna Rommens

  • Nucleotide deficiency promotes genomic instability in early stages of cancer development.

    Assaf C. Bester;Maayan Roniger;Yifat S. Oren;Michael M. Im

  • Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

    C. Castellani;H. Cuppens;M. Macek;J. J. Cassiman

  • Correlation between genotype and phenotype in patients with cystic fibrosis.

    Augarten A;Kerem Bs;Kerem E;Gazit E

  • Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

    Julian Zielenski;Richard Rozmahel;Dominique Bozon;Bat sheva Kerem

  • Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

    Michael Wilschanski;Yaacov Yahav;Yasmin Yaacov;Hannah Blau

  • Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

    B S Kerem;J Zielenski;D Markiewicz;D Bozon

  • Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

    Eitan Kerem;Samit Hirawat;Shoshana Armoni;Yasmin Yaakov

  • Recommendations for the classification of diseases as CFTR-related disorders

    Cristina Bombieri;M Claustres;K De Boeck;N Derichs

  • Developmental Dyscalculia Is a Familial Learning Disability

    Ruth S. Shalev;Orly Manor;Batsheva Kerem;Mady Ayali

  • A role for common fragile site induction in amplification of human oncogenes.

    Asaf Hellman;Eitan Zlotorynski;Stephen W Scherer;Joseph Cheung

  • Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin

    Liat Linde;Stephanie Boelz;Malka Nissim-Rafinia;Yifat S. Oren

  • Molecular basis for expression of common and rare fragile sites

    Eitan Zlotorynski;Ayelet Rahat;Jennifer Skaug;Neta Ben-Porat

  • Splicing regulation as a potential genetic modifier

    Malka Nissim-Rafinia;Batsheva Kerem

  • The presence of extra chromosomes leads to genomic instability.

    Verena Passerini;Efrat Ozeri-Galai;Mirjam S. de Pagter;Neysan Donnelly

  • A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations.

    Michael Wilschanski;Chagit Famini;Hannah Blau;Joseph Rivlin

  • Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.

    Wanda K. Lemna;Gerald L. Feldman;Bat-sheva Kerem;Susan D. Fernbach

Frequent Co-Authors

Johanna M. Rommens
Johanna M. Rommens University of Toronto
Lap-Chee Tsui
Lap-Chee Tsui University of Toronto
John R. Riordan
John R. Riordan University of North Carolina at Chapel Hill
Francis S. Collins
Francis S. Collins National Institutes of Health
Julian Zielenski
Julian Zielenski University of Toronto
Stephen W. Scherer
Stephen W. Scherer University of Toronto
Michal Schwartz
Michal Schwartz Weizmann Institute of Science
Pier Franco Pignatti
Pier Franco Pignatti University of Verona
Milan Macek
Milan Macek Charles University
Harry Cuppens
Harry Cuppens KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Genetics opens doors to diverse career options in healthcare, research, and education. Many students combine their genetics background with professional qualifications in nursing or advanced practice to increase job opportunities and earning potential.

For individuals interested in integrating genetics with clinical practice, several online pathways exist. Aspiring nurse practitioners can explore affordable fnp programs that offer flexible learning and specializations, which may include genetics-focused care. Some students begin their journey through an online nursing school to obtain foundational licensure and nursing skills.

For those looking to advance their careers further, the cheapest dnp programs can lead to leadership roles in genetics research, clinical practice, or academia. Alternatively, nurses with an associate degree may consider the best online rn to bsn programs to strengthen their credentials, potentially focusing on genetics within their studies.

Choosing an online program can provide flexibility, affordability, and access to specialized training—important factors for those wishing to align a genetics background with in-demand healthcare roles.

Best Scientists Citing Batsheva Kerem

Trending Scientists

Recently Published Articles